These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 21285460)
21. Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography. Acikel S; Muderrisoglu H; Yildirir A; Aydinalp A; Sade E; Bayraktar N; Bal U; Ozin B Blood Coagul Fibrinolysis; 2010 Dec; 21(8):750-7. PubMed ID: 20962623 [TBL] [Abstract][Full Text] [Related]
22. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine. Merkle M; Sauter M; Argirov M; Wörnle M Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272 [TBL] [Abstract][Full Text] [Related]
24. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007 [TBL] [Abstract][Full Text] [Related]
25. Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography. Madsen TE; Pearson RR; Muhlestein JB; Lappé DL; Bair TL; Horne BD; Anderson JL; Crit Pathw Cardiol; 2009 Dec; 8(4):167-71. PubMed ID: 19952552 [TBL] [Abstract][Full Text] [Related]
26. Haemodialysis for the prevention of contrast-induced nephropathy: outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review. Huber W; Jeschke B; Kreymann B; Hennig M; Page M; Salmhofer H; Eckel F; Schmidt U; Umgelter A; Schweigart U; Classen M Invest Radiol; 2002 Sep; 37(9):471-81. PubMed ID: 12218442 [TBL] [Abstract][Full Text] [Related]
27. Risk for contrast nephropathy in patients undergoing coronarography. La Manna G; Pancaldi LG; Capecchi A; Maska E; Comai G; Cappuccilli ML; Carretta E; Lombardi A; Colì L; Stefoni S Artif Organs; 2010 Jun; 34(6):E193-9. PubMed ID: 20482707 [TBL] [Abstract][Full Text] [Related]
28. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Nakamura T; Sugaya T; Node K; Ueda Y; Koide H Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622 [TBL] [Abstract][Full Text] [Related]
30. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. Marenzi G; Assanelli E; Marana I; Lauri G; Campodonico J; Grazi M; De Metrio M; Galli S; Fabbiocchi F; Montorsi P; Veglia F; Bartorelli AL N Engl J Med; 2006 Jun; 354(26):2773-82. PubMed ID: 16807414 [TBL] [Abstract][Full Text] [Related]
31. The incidence of contrast-induced nephropathy in trauma patients. Hipp A; Desai S; Lopez C; Sinert R Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952 [TBL] [Abstract][Full Text] [Related]
32. Determinants of amount of contrast utilized in patients undergoing percutaneous coronary procedures. Pradhan J; Niraj A; Afonso L Coron Artery Dis; 2007 Jun; 18(4):275-82. PubMed ID: 17496491 [TBL] [Abstract][Full Text] [Related]
33. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Josephson SA; Dillon WP; Smith WS Neurology; 2005 May; 64(10):1805-6. PubMed ID: 15911820 [TBL] [Abstract][Full Text] [Related]
34. Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. Yoshida S; Kamihata H; Nakamura S; Senoo T; Manabe K; Motohiro M; Sugiura T; Iwasaka T J Cardiol; 2009 Oct; 54(2):192-8. PubMed ID: 19782255 [TBL] [Abstract][Full Text] [Related]
35. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Marenzi G; Lauri G; Campodonico J; Marana I; Assanelli E; De Metrio M; Grazi M; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL Am J Med; 2006 Feb; 119(2):155-62. PubMed ID: 16443418 [TBL] [Abstract][Full Text] [Related]